Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.


UNLABELLED Current therapy of chronic hepatitis C is based on the combination of pegylated interferon-alpha and ribavirin. In spite of 50% sustained virological response, therapy is still limited by unsatisfying success rates with genotype 1 infections and adverse side effects. One attempt to increase success rates is triple combination therapy of… (More)


  • Presentations referencing similar topics